Cetirizine: A new H1, antagonist with antieosinophilic activity in chronic urticaria
- 31 October 1991
- journal article
- review article
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 25 (4) , 668-674
- https://doi.org/10.1016/0190-9622(91)70251-v
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- 568 The effect of cetirizine on eosinophil chemotaxis and release of eosinophil peroxidase (EPO) in human allergic subjectsJournal of Allergy and Clinical Immunology, 1991
- Late‐phase cutaneous reactions to platelet activating factor and kallikrein in urticariaClinical and Experimental Allergy, 1990
- In vivo effects of cetirizine on cutaneous reactivity and eosinophil migration induced by platelet-activating factor (PAF-acether) in manJournal of Allergy and Clinical Immunology, 1990
- Pharmacologic modulation by cetirizine 2 HCl and loratadine of the histamine‐induced skin reaction in mice and in humansDrug Development Research, 1989
- RELEASE OF PAF-ACETHER AND PRECURSORS DURING ALLERGIC CUTANEOUS REACTIONSThe Lancet, 1988
- Adherence of human basophils to cultured umbilical vein endothelial cells.Journal of Clinical Investigation, 1988
- Effects of platelet activating factor on the chemotaxis of normodense eosinophils from normal subjectsBiochemical and Biophysical Research Communications, 1987
- ACCUMULATION OF EOSINOPHILS IN RESPONSE TO INTRACUTANEOUS PAF-ACETHER AND ALLERGENS IN MANThe Lancet, 1986
- Leukocyte Activation in Allergen-Induced Late-Phase Asthmatic ReactionsNew England Journal of Medicine, 1984
- Cutaneous eosinophil accumulation in atopic and non‐atopic individuals: the effect of an ECF‐A tetrapeptide and histamineClinical and Experimental Allergy, 1977